ClinicalTrials.gg
CompletedNCT07219355Updated Oct 27, 2026

Virtual Reality Lethal Means Safety Training

An interventional study of Virtual Reality Lethal Means Safety Training and 2D Video Training in Suicide, Attempted, Suicide, Completed and Suicide Prevention, sponsored by The University of Texas at Arlington. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by The University of Texas at Arlington · Not applicable, Interventional, and Other

How we know

Updated Oct 27, 2026Now CompletedStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 149 studies in Suicide, Attempted with a site in United States — 53 open to participants now, 58 under way, 1 of them phase 3. Suicide, Attempted · United States.

Enrollment
113th of 140
36 · median 117
Started
2026
with 12 others
No phase
121 of 149
49 open now
Registered
138th of 149
by date

Among the 149 studies in Suicide, Attempted with a site in United States, this one is the 113th largest by enrollment of the 140 interventional ones that give a count, is one of 13 that started in 2026, is one of 121 with no phase, and was the 138th registered.

Suicide, Attempted

281 studies on the registry are indexed under Suicide, Attempted; 90 are open to participants now.

Browse Suicide, Attempted studies →

Open to participants now

53 of the 149 studies in Suicide, Attempted with a site in United States are open now. Recruiting first, the newest first:

48 more — sign in →

All 53 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 67 Suicide, Attempted studies recruiting now, 34 (51%) set no upper age limit and 32 (48%) stop at 75 or younger; 28 take children under 18; 11 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 149 studies in Suicide, Attempted with a site in United States, or all of them as a file.
02

Study summary

The goal of this randomized clinical trial is to determine whether a virtual reality (VR) training program can help healthcare providers improve their skills in discussing suicide prevention and safe storage of firearms and medications with Veterans. The study will test whether VR training increases providers' self-efficacy, confidence, and comfort in conducting lethal means safety counseling, and whether it improves their intention to use these counseling practices in their clinical work. Researchers will compare healthcare providers who complete the VR training to those who complete a 2D video training to determine whether the VR approach is more effective. Participants will complete online surveys before and after the training and again three months later. They will be randomly assigned to one of two groups: VR training group: Participants use a VR headset to interact with a virtual Veteran patient in a simulated rural clinic and practice suicide prevention counseling skills; Video training group: Participants use the same headset to watch a \~10-minute 2D video depicting the lethal means safety counseling session. After the training, participants will also provide feedback about their experience, including how realistic and useful they found the training.

Read the detailed description

This study will test whether a virtual reality (VR) training program can improve healthcare providers' ability to talk with Veterans about suicide prevention and safe storage of firearms and medications. Rural Veterans have suicide rates much higher than the national average, and providers in rural areas often do not receive enough training in suicide risk identification or lethal means safety counseling.

This project builds on our prior Veteran Suicide Assessment in Virtual Reality (VET-SAVR) study, which showed that VR can be a feasible and acceptable way to deliver suicide prevention training. In the current study, called the Virtual Reality Lethal Means Safety Training (VR-LMST) project, we will compare an immersive VR training simulation to a 2D video training.

Study Aims

Aim 1: Develop a VR training simulation focused on suicide prevention counseling with rural Veterans.

Aim 2: Test whether VR-LMST improves provider confidence (primary), and comfortability and intention (secondary) to engage in lethal means safety counseling.

Aim 3: Assess user experience of the VR simulation, including presence, realism, acceptability, feasibility, and tolerability.

Study Design

This is a randomized controlled trial. Participants will be assigned to one of two groups:

VR-LMST group: Participants will use a VR headset (Meta Quest 3) to enter a simulated rural clinic visit with a Veteran avatar who presents with thoughts of suicide. They will practice counseling skills related to safe firearm and medication storage.

2D Video group: Participants will use a VR headset to view a 10-minute video showing a provider having a lethal means safety conversation with a Veteran.

Assessments

Pre-test, post-test, and 3-month follow-up surveys will be completed online.

The Counseling on Access to Lethal Means (CALM) Core Scale (13 items) will measure provider confidence (1-5), comfortability (6-8), and intentions (9-13). An additional two items measure counseling behavior at 3 months (14-15).

The ITC-Sense of Presence Inventory (ITC-SOPI) will measure presence, naturalness, engagement, and negative effects.

Open-ended questions will gather feedback about realism, acceptability, and feasibility.

Demographic and professional background information will also be collected.

Sample Size and Timeline Thirty-six participants enrolled and completed the randomized trial (18 per group). Power analysis indicated this sample size is sufficient to detect moderate effects with 80% power for the primary outcome.

Phase 1 (completed): Recruited 11 healthcare providers for qualitative interviews; conducted coding and analysis; developed and refined VR and 2D scripts.

Phase 2 (completed): Prototype VR clinic environment developed through iterative meetings with VR developers.

Phase 3 (completed): Pilot playtesting in October 2025 with 5 participants, followed by refinement of the simulation through March 1, 2026.

Phase 4 (completed): Randomized trial enrollment began March 4, 2026.

Phase 5 (completed): 3-month follow-up assessments were completed September 4, 2026.

Oversight IRB approval was received September 27, 2024, from the University of Texas at Arlington. This study is funded by the American Foundation for Suicide Prevention (AFSP).

Significance This project will test a novel, scalable training method to give healthcare providers repeated opportunities to practice suicide prevention counseling in a safe environment. By equipping rural providers with the skills and confidence to have culturally sensitive, Veteran-centered conversations about firearm and medication safety, VR-LMST has the potential to improve clinical practice and reduce suicide risk among rural Veterans.

03

Conditions studied

  • Suicide, Attempted
  • Suicide, Completed
  • Suicide Prevention
  • Mental Health Training
  • Rural Health
  • Veterans

Keywords

  • Veterans
  • Rural Veterans
  • Suicide Prevention
  • Suicide Risk
  • Firearm Safety
  • Medication Safety
  • Lethal Means Safety Counseling
  • Virtual Reality (VR)
  • VR Training Simulation
  • Rural Health
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 or older
  • healthcare providers serving rural Veterans in Texas (e.g., physicians, physician assistants, nurse practitioners, nurses, pharmacists, social workers, healthcare case managers)
  • English-speaking
  • Able to provide

Exclusion criteria

Exclusion Criteria:

  • Self-reported pregnancy
  • History of motor or balance disorders
  • Color blindness
  • Neurological or cognitive disorders
  • Cardiovascular issues that may be worsened by VR use
  • Use of cardiac pacemakers, defibrillators, or hearing aids incompatible with VR equipment
  • Significant discomfort in virtual reality environments (e.g., severe motion sickness, vertigo)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    VR-LMST Intervention

    Participants use a Meta Quest 3 headset to complete an interactive virtual reality simulation of a rural clinic visit with a Veteran avatar at risk for suicide. The simulation incorporates skills in suicide risk identification, firearm and medication safety counseling, and collaborative safety planning.

    Behavioral: Virtual Reality Lethal Means Safety Training

  • Active comparator
    2D Video Training

    Participants use a VR headset to view a 10-minute 2D video depicting a lethal means safety counseling session with a veteran.

    Behavioral: 2D Video Training

Interventions

  • BehavioralVirtual Reality Lethal Means Safety Training

    An immersive behavioral training program delivered through a Meta Quest 3 virtual reality headset. Participants enter a simulated rural health clinic and interact with a Veteran avatar at risk for suicide. The simulation incorporates realistic dialogue and decision points where providers practice skills in suicide risk identification, lethal means safety counseling (firearm and medication storage), and collaborative safety planning. The VR format allows repeated practice in a safe environment and provides a more engaging and realistic training experience than traditional methods.

  • Behavioral2D Video Training

    A 10-minute video delivered through a VR headset that depicts a healthcare provider conducting lethal means safety counseling with a Veteran. This is a non-interactive training used as an active comparator.

06

What researchers measure

Primary outcomes

  1. Confidence in Lethal Means Safety Counseling

    Measured by the Counseling on Access to Lethal Means (CALM) Core Scale (Sale et al., 2018) Confidence subscale ("How confident are you that …"). Items are rated on a 4-point scale and summed; higher scores indicate greater confidence (range = 5 - 20).

    Time frame: Baseline (pre-test), immediately after intervention (post-test), and 3-month follow-up

Secondary outcomes

  1. Comfortability in Lethal Means Safety Counseling

    Measured by the Counseling on Access to Lethal Means (CALM) Core Scale (Sale et al., 2018) Comfortability subscale ("How comfortable are you talking about …"). Includes 3 items where 1 = Not Very Comfortable to 4 = Extremely Comfortable. Items are rated on a 4-point scale and summed (range = 3 - 12). Higher scores indicating greater comfort initiating suicide or means-restriction discussions.

    Time frame: Baseline (pre-test), immediately after intervention (post-test), and 3-month follow-up

  2. Counseling Intentions

    Measured by the Counseling on Access to Lethal Means (CALM) Core Scale (Sale et al., 2018) Counseling Intentions subscale ("If you recognize warning signs of suicide in an individual, how likely are you to…"). Includes 5 items where 1 = Not Very Likely to 4 = Extremely Likely. Items are rated on a 4-point scale and summed (range = 5-20). Higher scores indicate stronger intentions to engage in suicide-prevention and lethal-means safety counseling behaviors.

    Time frame: Baseline (pre-test), immediately after intervention (post-test), and 3-month follow-up

  3. Spatial Presence

    Measured by the ITC-Sense of Presence Inventory (Lessiter et al., 2001) Spatial Presence subscale ("During my experience of the displayed environment…"). Includes 19 items (e.g., "I felt as though I was in the same space as the characters and/or objects") rated on a 5-point scale where 1 = Strongly Disagree to 5 = Strongly Agree. Items are averaged to create a mean subscale score (range = 1 - 5). Higher scores indicate a stronger sense of "being there" or physical immersion within the virtual environment.

    Time frame: Immediately after intervention (post-test only)

  4. Engagement

    Measured by the ITC-Sense of Presence Inventory (Lessiter et al., 2001) Engagement subscale ("During my experience of the displayed environment…"). Includes 13 items (e.g., "I felt myself being drawn in") rated on a 5-point scale where 1 = Strongly Disagree to 5 = Strongly Agree. Items are averaged to create a mean subscale score (range = 1 - 5). Higher scores indicate greater emotional and cognitive involvement in the displayed environment.

    Time frame: Immediately after intervention (post-test only)

  5. Ecological Validity / Naturalness

    Measured by the ITC-Sense of Presence Inventory (Lessiter et al., 2001) Ecological Validity / Naturalness subscale ("During my experience of the displayed environment…"). Includes 5 items (e.g., "The scenes depicted could really occur in the real world") rated on a 5-point scale where 1 = Strongly Disagree to 5 = Strongly Agree. Items are averaged to create a mean subscale score (range = 1 - 5). Higher scores indicate greater perceived realism and naturalness of the virtual environment.

    Time frame: Immediately after intervention (post-test only)

  6. Negative Effects (Tolerability)

    Tolerability will be measured by the ITC-Sense of Presence Inventory (Lessiter et al., 2001) Negative Effects subscale ("During my experience of the displayed environment…"). Includes 6 items (e.g., "I felt dizzy," "I felt nauseous") rated on a 5-point scale where 1 = Strongly Disagree to 5 = Strongly Agree. Items are averaged to create a mean subscale score (range = 1 - 5). Higher scores indicate greater discomfort or simulator-related side effects (e.g., dizziness, eyestrain, nausea) and thus, lower tolerability.

    Time frame: Immediately after intervention (post-test only)

Other outcomes

  1. Feasibility of VR Training (Qualitative)

    Feasibility (extent to which the intervention can be successfully used, delivered, or implemented as intended in a real-world setting) will be assessed through open-ended post-training survey questions and short debrief interviews. Participants will provide qualitative feedback on how realistic and useful they perceived the VR simulation (or 2D video) by responding to prompts such as: "What elements could be included to make the VR training more realistic and representative?" and "Please add any comments you'd like to make about your experience with the VR training." Responses will be coded thematically using qualitative analysis software to identify key themes related to feasibility (ease of use, technical functionality, time burden, and perceived fit for training or clinical settings), as well as related dimensions of realism, training value, and applicability to professional practice.

    Time frame: Immediately after intervention (post-test only)

  2. Acceptability (Qualitative)

    Acceptability (extent to which participants find an intervention appropriate, satisfying, and relevant to their professional role or setting) will be measured by open-ended response to "How much do you agree that the VR training was representative of speaking with a veteran experiencing suicide/depression about lethal means safety?" and provide additional open-ended feedback describing their perceptions of training value, satisfaction, and authenticity. Responses will be coded thematically using qualitative analysis software to identify key themes related to acceptability (appropriateness, satisfaction, and perceived usefulness of the training).

    Time frame: Immediately after intervention (post-test only)

07

Study locations

1 site
  • University of Texas at Arlington
    Arlington, Texas 76019, United States
08

References and documents

Publications

  • Sale E, Hendricks M, Weil V, Miller C, Perkins S, McCudden S. Counseling on Access to Lethal Means (CALM): An Evaluation of a Suicide Prevention Means Restriction Training Program for Mental Health Providers. Community Ment Health J. 2018 Apr;54(3):293-301. doi: 10.1007/s10597-017-0190-z. Epub 2017 Nov 28. PubMed 29185154 ↗
  • Hunter AA, DiVietro S, Boyer M, Burnham K, Chenard D, Rogers SC. The practice of lethal means restriction counseling in US emergency departments to reduce suicide risk: a systematic review of the literature. Inj Epidemiol. 2021 Sep 13;8(Suppl 1):54. doi: 10.1186/s40621-021-00347-5. PubMed 34517912 ↗
  • Hoyt T, Holliday R, Simonetti JA, Monteith LL. Firearm Lethal Means Safety with Military Personnel and Veterans: Overcoming Barriers using a Collaborative Approach. Prof Psychol Res Pr. 2021 Aug;52(4):387-395. doi: 10.1037/pro0000372. Epub 2021 May 20. PubMed 34421193 ↗
  • Diurba S, Johnson RL, Siry BJ, Knoepke CE, Suresh K, Simpson SA, Azrael D, Ranney ML, Wintemute GJ, Betz ME. Lethal Means Assessment and Counseling in the Emergency Department: Differences by Provider Type and Personal Home Firearms. Suicide Life Threat Behav. 2020 Oct;50(5):1054-1064. doi: 10.1111/sltb.12649. Epub 2020 Jun 29. PubMed 32598076 ↗
  • Boggs JM, Quintana LM, Powers JD, Hochberg S, Beck A. Frequency of Clinicians' Assessments for Access to Lethal Means in Persons at Risk for Suicide. Arch Suicide Res. 2022 Jan-Mar;26(1):127-136. doi: 10.1080/13811118.2020.1761917. Epub 2020 May 7. PubMed 32379012 ↗

Individual participant data

Plan to share: No — This study collects survey and qualitative data from a small sample of healthcare providers. Because of the limited sample size and potential identifiability of responses, individual participant data (IPD) will not be shared. Aggregate data will be shared in publications and presentations.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2026 to primary completion in Sep 2026, 6 months.

Of 145 non-industry interventional studies with no phase under Suicide, Attempted, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 56. This study's 6 months is below that.

Counting every sponsor, half of 147 studies reached it within 37 months; a quarter within 20 and three quarters within 56.

Start moved once since we started tracking on Sep 25, 2026: Feb 2026 → Mar 2026, on Oct 27, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2025
First posted
Oct 21, 2025
StartActual
Mar 4, 2026was Feb 2026
Primary completionActual
Sep 4, 2026
CompletionActual
Sep 4, 2026
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 2, 2026
Start date
Feb 23, 2026→Mar 4, 2026
Oct 27, 2026
Primary completion
Sep 15, 2026→Sep 4, 2026
moved 2 times, Oct 2, 2026 – Oct 27, 2026
Study completion
Sep 30, 2026→Sep 4, 2026
Oct 27, 2026
Show all 2 updates
  1. Oct 27, 2026
    Start date Feb 23, 2026→Mar 4, 2026
    Primary completion Aug 31, 2026→Sep 4, 2026
    Study completion Sep 30, 2026→Sep 4, 2026
    + 1 other change: description
  2. Oct 2, 2026
    Active, not recruiting→Completed
    Primary completion Sep 15, 2026→Aug 31, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07219355
Lead sponsor
The University of Texas at Arlington
Collaborators
American Foundation for Suicide Prevention
Responsible party
Sponsor
First posted
Oct 21, 2025
Start date
Mar 4, 2026
Primary completion
Sep 4, 2026
Completion
Sep 4, 2026
Last update
Oct 27, 2026

Study contacts

Donna L. Schuman, PhD, LCSW
principal investigator · University of Texas at Arlington, School of Social Work

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion